Report: Government oversight threatens California's biotech boom

01/23/2008 | Forbes

Biotech businesses in California -- including those focused on drug development, medical devices and diagnostics -- brought in more than 40% of the $7.4 billion in biotech venture capital in 2006, according to a new PriceWaterhouseCoopers report. The industry's steady growth could be hampered, however, as the federal government is likely to have increased involvement in oversight of drug safety and cost-effectiveness.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr Statistician I (US/TB/00/0028/SL)
Abbott
Santa Clara, CA
Food & Drug Associate
Confidential
Washington, D.C., DC
Senior Manager, Gaps in Care
UAW Retiree Medical Benefits Trust
Detroit, MI
Compliance Director
Abbott Laboratories
Santa Clara, CA
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA